Literatur

Probiotic Escherichia coli Nissle 1917 versus placebo for treating diarrhea of greater than 4 days duration in infants and toddlers.

In: Pediatr. Infect. Dis. J. 27 (6), S. 494–499.

Weitere Veröffentlichungen:

Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis. A randomised trial.

Weitere Informationen

Potenzial von Escherichia coli Nissle 1917 in der Behandlung des septischen Schocks

Weitere Informationen

The use of Escherichia coli strain Nissle 1917 shows promise for improving gastrointestinal and urinary health in dogs

Weitere Informationen

Henker, J.; Laass, M. W.; Blokhin, B. M.; Maydannik, V. G.; Bolbot, Y. K.; Elze, M. et al. (2008): Probiotic Escherichia coli Nissle 1917 versus placebo for treating diarrhea of greater than 4 days duration in infants and toddlers.